Subscribe to our Newsletter
Join Pharma Tech Outlook's mailing list for the latest articles, news, and exclusive insights from seasoned pharma industry experts.
By James Mogavero, Director of IT, Northwell Health
After working in technology for over twenty years I've found that no matter which sector you work in many of the IT related processes are the same....
By Lisa Emery, CIO, West Hertfordshire Hospitals NHS Trust
To achieve success you need to be a great communicator, able to understand the broad needs of the business and translate from technical terms to real benefits.
By Xavier Flinois, President, PAREXEL Informatics
Qualified Clinical Research Organizations (CROs) are now making technology decisions when it comes to the development and execution of clinical trials,
By Sanaz Motahari, CPO, Brite Health
A pillar of any behavior change framework is understanding the unique differences between people and delivering the elements of the framework at the right moment.
By Keith Perry, CIO & SVP, St. Jude Children's Research Hospital
It is an inspiring time to be working at the intersection of technology and health care. At St. Jude Children’s Research Hospital, we understand that technology is fundamental to accomplishing our mission.
By Leo Barella, VP, Enterprise Architecture, AstraZeneca [NYSE:AZN]
Architectural or engineering principles are the cornerstone of the Enterprise Architecture.
By Susan Weidner, Senior Vice President, IntrinsiQ Specialty Solutions, a part of AmerisourceBergen
Precision medicine –fueled by technological advances, scientific breakthroughs and significant financial investments – has the potential to improve patient lives all around the world.
By Chris Larkin, General Manager, Software Engineering - GE Healthcare, Life Sciences
The cloud has the potential to offer incredible asset performance management benefits for the pharmaceutical industry.
By Matt Lasmanis, US CIO, GSK [LSE:GSK] [NYSE:GSK]
Over the last decade, we’ve seen digital technology disrupt business as usual, drive remarkable returns for some companies, and utterly change the way we all live—from how we order a taxi to planning our next meal.
By Richard Hu, Associate Director CMC, Curis
For cancer patients, chemotherapy and radiation therapy have long been the only options. Recent development of immuno-oncology has changed the game.
By Neil Aubuchon, VP-Global Marketing, Santen
Randomized, placebo-controlled Phase III clinical trials (or RCT’s for short) traditionally have been considered the gold standard for evidence in the pharmaceutical industry.
By Rick White, CIO, Sotera Defense Solutions, Inc.
DataViz is pervasive in both print and web media and this has served to further raise the bar for succinct and effective messaging.
By Robert Jan van der Horst, CIO, DSM Sinochem Pharmaceuticals
Pharmaceutical Serialisation is the tracking and tracing of the passage of prescription drugs through the supply chain from manufacturing to dispensing to the patient.
By Rhonda Medows, M.D., EVP of Population Health, Providence St. Joseph Health And Deepak Sadagopan, VP of Population Health informatics and government programs, Providence St. Joseph Health
With the increasing emphasis on value-based care, population health will continue as a driving force for American health systems.
By James Cai, Head of Data Science, Roche
To fully realize the power of AI, it is important for both pharma and academia to invest in research at the intersection of AI and biomedicine. It is also imperative to systematically generate high quality, properly labeled data.
